Leishmaniasis: A re-emerging zoonosis

International Journal of Dermatology

Volumn 37, Issue 11, 1998, Pages 801-814

  Marsella, Rosanna ^a,c   De Gopegui, Rafael Ruiz ^b  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c University of Florida College of Veterinary Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIMONY; COTRIMOXAZOLE; CYTOKINE; DAPSONE; INTERFERON; INTERLEUKIN 12; ISONIAZID; ITRACONAZOLE; KETOCONAZOLE; MEGLUMINE; METRONIDAZOLE; PAROMOMYCIN; RIFAMPICIN; STIBOCAPTATE; XANTHINE OXIDASE INHIBITOR;

CLINICAL FEATURE; CRYOTHERAPY; DISEASE CARRIER; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; GRANULOMATOUS INFLAMMATION; HUMAN; LEISHMANIA INFANTUM; LEISHMANIASIS; LIFE CYCLE; MORPHOLOGY; NONHUMAN; RESERVOIR; REVIEW; ZOONOSIS;

ANIMALS; DISEASE RESERVOIRS; HOST-PARASITE RELATIONS; HUMANS; LEISHMANIA; LEISHMANIASIS; ZOONOSES;

EID: 3643147873     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1998.00449.x     Document Type: Review

References (45)

1. Hommel M, Jaffe CL, Travi B, Milon G. Experimental models for leishmaniasis and for testing anti-leishmanial vaccines. Ann Trop Med Parasitol I995; 89: S55-S73.
2. Ashford RW, Desjeux P, DeRaadt P. Estimation of population at risk of infection and number of cases of leishmaniasis. Parasitol Today I992.; 8: I04-I05.
3. Magill A, Gragl M, Gasser J, et al. Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N Engl J Med I993; 328: I383-I385.
4. Gorgolas De M, Miles MA. Visceral leishmaniasis and AIDS. Nature I994; 372: 33.
5. Kerr SF, McHugh CP, Dronen NO Jr. Leishmaniasis in Texas; prevalence and seasonal transmission of Leishmania mexicana in Neotoma micropus. Am J Trop Med Hyg I995; 53: 73-77.
6. Grimalidi G Jr, Tesh RB, McMahon-Pratt D. A review of the geographic distribution and epidemiology of leishmaniasis in the New World. Am J Trop Med Hyg I989; 41: 687-725.
7. Pizzirani S. La Leishmaniosi Canina. Bologna, Italy: Grasso Editor, I989: 4-6.
8. Hall LR, Titus RG. Sand fly vector saliva selectively modulates macrophage functions that inhibit killing of Leishmania major and nitric oxide production. J Immunol I995; 155: 350I-3506.
9. Magill AJ. Epidemiology of the leishmaniases. Dermatol Clin I995; 13: 505-523.
10. I0 Tremblay M, Olivier M, Bernier R. Leishmania and the pathogenesis of HIV infection. Parasitol Today I996; 12: 257-261.
11. Hall BF, Joiner KA. Strategies of obligate intracellular parasites for evading host defenses. Parasitol Today I99I; 12.: A22-A27.
12. I2 Bettini S, Gramiccia M, Gradoni L, et al. Leishmaniasis in Tuscany (Italy) VIII. Human population response to leishmanin in the focus of Monte Argentario (Grosseto) and epidemiological evaluation. Ann Parasitol Hum Comp I983; 58: 539-547.
13. I3 Bettini S, Gradoni L. Canine leishmaniasis in the Mediterranean area and its implication for human leishmaniasis. Insect Sci Appl I986; 7: 24I-245.
14. I4 Swenson CL, Silverman J, Stromberg PC, et al. Visceral leishmaniasis in an English foxhound from an Ohio research colony. J Am Vet Med Assoc I988; 193: I089-I092.
15. I5 Barnes JC, Stanley O, Craig TM. Diffuse cutaneous leishmaniasis in a cat. J Am Vet Med Assoc I993; 202: 4I6-4I8.
16. I6 McHugh CP, Melby PC, LaFon SG. Leishmaniasis in Texas: epidemiology and clinical aspects of human cases. Am J Trop Med Hyg I996; 55: 547-555.
17. Locksley RM, Scott P. Helper T-cell subsers in mouse leishmaniasis: induction, expansion and effector functions. Jmmunol Today I99I; 12: A58-A61.
18. Martlnez-Moreno A, Moreno T, Martínez-Moreno FJ, et al. Humoral and cell-mediated immunity in natural and experimental canine leishmaniasis. Vet Immunol Immunopath I995; 48: 209-220.
19. Liew FY, O'Donnel CA. Immunology of leishmaniasis. Adv Parasitol I993; 32: I6I-259.
20. Kennan CM, Hendricks LD, Lightner L, Johnson AJ. Visceral leishmaniasis in the German Shepherd dog. II. Pathology. Vet Pathology I984; 21: 80-86.
21. Pisa P, Gennene M, Soder O, et al. Serum tumor necrosis factor levels and disease dissemination in leprosy and leishmaniasis. J Infect Dis I990; 161: 988-991.
22. Fitzparrick TB, Eisen AZ, Wolff K, et al. Dermatology in General Medicine, Volume II, 4th edn. New York: McGraw-Hill, I993: 2772-2777.
23. Kontos VJ, Koutinas AF. Old World canine leishmaniasis. The Compendium I993; 15: 949-959.
24. Bunn-Moreno MM, Madeira ED, Miler K, et al Hypergammaglobulinemia in Leishmania donovani infected hamsters: possible association with a polyclonal activator of B cells and with suppression of T cell function. Immunology I985; 59: 427-434.
25. Hervás-Rodríguez J, Mozos E, Méndez A, et al. Leishmania infection of canine skin fibroblasts in vivo. Vet Pathol I996; 33: 469-473.
26. Oliveira GGS, Santoro F, Sagidurski M. The subclinical form of experimental visceral leishmaniasis in dogs. Mem Inst Oswalso Cruz I993; 88: 243-248.
27. Sells PG, Burton M. Identification of Leishmania amastigotes and their antigens in formalin fixed tissue by immunoperoxidase staining. Trans R Soc Trop Med Hyg I98I; 75: 46I-468.
28. Mathis A, Deplazes P. PCR and in vitro cultivation for detection of Leishmania spp. in diagnostic samples from humans and dogs. J Clin Microbiol I995; 33: II45-II49.
29. Millesimo M, Zucca M, Caramello P, Savoia D. Evaluation of the immune response in visceral leishmaniasis. Diag Microbiol Infect Dis I996; 26: 7-II.
30. Mengistu G, Akuffo H, Fehniger TE, et al. Comparison of parasitological and immunological methods in the diagnosis of leishmaniasis in Ethiopia. Trans R Soc Trop Med Hyg I992; 86: I54-I57.
31. 3I Mancianti F, Meciani N. Specific serodiagnosis of canine leishmaniasis by indirect immunofluorescence, indirect hemagglutination, and counter-immunoelectrophoresis. Am J Vet Res I988; 49: 1409-1411.
32. Hommel M, Peters W, Ranque J, et al. The micro-ELISA technique in serodiagnosis of visceral leishmaniasis. Ann Trop Med Parasitol I978; 71: 213-218.
33. Pappas MG, Hajkowski R, Hockmeyer WT. Dot enzyme-linked immunosorbent assay (Dot-ELISA): a microtechnique for the rapid diagnosis of visceral leishmaniasis. J Immunol Methods I983; 64: 205-214.
34. Gari-Toussaint M, Lelièvre A, Marty P, et al. Contribution of serological tests to the diagnosis of visceral leishmaniasis in patients infected with the human immunodeficiency virus. Trans R Soc Trop Med Hyg I994; 88: 301-330.
35. Nigro L, Vinci C, Romano F, Russo R. Comparison of the indirect immunofluorescent antibody test and the direct agglutination test for serodiagnosis of visceral leishmaniasis in HIV-infected subjects. Eur J Clin Microbiol Infect Dis I996; 15: 832-835.
36. 2 acidic ribosomal proteins. Clin Diagn Lab Immunol I996; 3: 387-391.
37. Ghanem BM, El-Shazly AM, Fawzy M, et al. Allopurinol in the treatment of zoonotic cutaneous leishmaniasis. J Egypt Soc Parasitol I996; 26: 6I9-628.
38. Brajtburg J, Bolard J. Carrier effects on biological activity of amphotericin B. Clin Microbiol Rev I996; 9: 5I2-53I.
39. Murray HW. Current and future clinical applications of interferon-gamma in host antimicrobial defense. Intensive Care Med I996; 22: S456-S461.
40. Chance ML. New developments in the chemotherapy of leishmaniasis. Ann Trop Med Parasitol I995; 89: 37-43.
41. Berman JD. Treatment of New World cutaneous and mucosaJ leishmaniases. Clin Dermatol I996; 14: 5I9-522.
42. Alvar G, Gutiérrez-Solar B, Pachón I, et al. AIDS and Leishmania infantum. Clin Dermatol I996; 14: 54I-546.
43. Basimike M, Mutinga MJ. Effects of permethrin-treated screens on phlebotomine sand flies, with reference to Phlebotomus martini. J Med Entomol I995; 32: 428-432.
44. Schlein Y, Jacobson R. Mortality of Leishmania major in Phlebotomus papatasi caused by plant feeding of the sand flies. Am J Trop Med Hyg I994; 50: 20-25.
45. Modabber F. Vaccines against leishmaniasis, Ann Trop Med Parasitol I995; 89: 83-88.